Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Molecular Probes Licenses Fluorescence Technology

Photonics.com
Apr 2003
EUGENE, Ore. and HUDDINGE, Sweden, April 10 -- LightUp Technologies, a Swedish developer of molecular-based technologies for medical diagnostic uses, said it will launch DNA analysis products using technology it has licensed from Molecular Probes, an Oregon-based developer of fluorescence-based detection methods for scientific and biomedical research.

Molecular Probes will supply advanced reactive stains for LightUp Technologies' LightUp Probe products, which LightUp expects to begin marketing to the health care community in May. LightUp Probes are short peptide nucleic acid conjugates that increase in fluorescence when hybridized to target sequences. LightUp Probe products identify and quantify the presence of bacteria, viruses and other pathogens by detecting and analyzing DNA.

Molecular Probes said its reactive nucleic acid stains exhibit a hundred-fold to a thousand-fold increase in fluorescence upon binding to nucleic acids and are designed to spectrally match commonly used fluorescence detection instrumentation. The initial product will be an assay for the detection and quantification of cytomegalovirus, to be marketed under the brand name ReSSQ CMV. Additional products will follow.

Financial terms of the licensing agreement were not disclosed.

For more information, visit: www.probes.com



Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.